Published in Cancer Res on February 01, 1979
Endogenous Retinoic Acid Required to Maintain the Epidermis Following Ultraviolet Light Exposure in SKH-1 Hairless Mice. Photochem Photobiol (2015) 1.99
Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci U S A (1997) 1.47
Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci U S A (1989) 1.26
A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila) (2010) 1.21
Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci U S A (1981) 1.10
Role of protein kinase C in diacylglycerol-mediated induction of ornithine decarboxylase and reduction of epidermal growth factor binding. Proc Natl Acad Sci U S A (1985) 1.08
Activators of protein kinase C trigger cortical granule exocytosis, cortical contraction, and cleavage furrow formation in Xenopus laevis oocytes and eggs. J Cell Biol (1989) 1.03
Tumor-promoting phorbol esters inhibit procollagen synthesis at a pretranslational level in JB-6 mouse epidermal cells. Mol Cell Biol (1983) 1.00
Retinoids and phorbol esters alter release of fibronectin from enucleated cells. Proc Natl Acad Sci U S A (1982) 0.99
Retinoids increase transglutaminase activity and inhibit ornithine decarboxylase activity in Chinese hamster ovary cells and in melanoma cells stimulated to differentiate. Proc Natl Acad Sci U S A (1982) 0.97
alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc Natl Acad Sci U S A (1982) 0.96
Hyperphosphorylation of N-60, a protein structurally and immunologically related to nucleolin after tumour-promoter treatment. EMBO J (1988) 0.96
Virucidal activity of retinal. Antimicrob Agents Chemother (1979) 0.94
Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response. Invest New Drugs (2009) 0.93
Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice. Carcinogenesis (2008) 0.91
Cell surface dynamics of neutrophils stimulated with phorbol esters or retinoids. J Cell Biol (1987) 0.85
all-trans-Retinal stimulates superoxide release and phospholipase C activity in neutrophils without significantly blocking protein kinase C. Proc Natl Acad Sci U S A (1986) 0.83
Difluoromethylornithine: the proof is in the polyamines. Cancer Prev Res (Phila) (2012) 0.81
Increased mouse epidermal ornithine decarboxylase activity by the tumour promoter 12-O-tetradecanoylphorbol 13-acetate involves increased amounts of both enzyme protein and messenger RNA. Biochem J (1986) 0.80
Differential response to retinoic acid of Syrian hamster embryo fibroblasts expressing v-src or v-Ha-ras oncogenes. Mol Cell Biol (1986) 0.80
Lack of enhancement of experimental photocarcinogenesis by topical retinoic acid. Arch Dermatol Res (1981) 0.80
The role of free radicals in tumor promotion. Environ Health Perspect (1989) 0.80
Inhibition of carcinogenesis by retinoids. Can Med Assoc J (1980) 0.79
Increased colonic ornithine decarboxylase activity in inflammatory bowel disease in children. Dig Dis Sci (1999) 0.79
New classes of environmental tumor promoters: indole alkaloids and polyacetates. Environ Health Perspect (1983) 0.75
Effect of retinoic acid on asbestos induced plasminogen activator activity of peritoneal macrophages. Br J Ind Med (1989) 0.75
Mechanisms of asbestos-induced squamous metaplasia in tracheobronchial epithelial cells. Environ Health Perspect (1989) 0.75
Mechanism of virucidal activity of retinoids: protein removal from bacteriophage phi 6 envelope. Antimicrob Agents Chemother (1980) 0.75
The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol (1974) 3.36
Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res (1975) 2.14
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene (2001) 2.08
Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice. Carcinogenesis (1980) 1.55
Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J Biol Chem (1988) 1.50
Pulmonary function profile in patients with benign goiters without symptoms of respiratory compromise and the early effect of thyroidectomy. J Postgrad Med (2008) 1.48
Protein kinase activity associated with a phorbol ester receptor purified from mouse brain. Cancer Res (1983) 1.37
Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res (1975) 1.36
Identification of a calcium- and phospholipid- dependent phorbol ester binding activity in the soluble fraction of mouse tissues. Biochem Biophys Res Commun (1983) 1.34
Studies on the mechanism of skin tumor promotion. Cancer Res (1970) 1.29
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Res (1978) 1.27
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res (2001) 1.26
The binding of beta-propiolactone to mouse skin DNA in vivo; its correlation with tumor-initiating activity. Cancer Res (1966) 1.25
Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res (1977) 1.22
The rate of activation by calmodulin of isoform 4 of the plasma membrane Ca(2+) pump is slow and is changed by alternative splicing. J Biol Chem (1999) 1.21
The Ca2+ affinity of the plasma membrane Ca2+ pump is controlled by alternative splicing. J Biol Chem (1994) 1.20
A highly active 120-kDa truncated mutant of the plasma membrane Ca2+ pump. J Biol Chem (1993) 1.18
Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem J (1996) 1.17
Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India (2003) 1.15
Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.15
Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res (2000) 1.13
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia (2010) 1.13
A pilot study of same day sputum smear examination, its feasibility and usefulness in diagnosis of pulmonary TB. Indian J Tuberc (2011) 1.12
Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. Cancer Res (1971) 1.12
Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1999) 1.11
The stimulation of phospholipid metabolism in mouse skin following phorbol ester treatment. Biochim Biophys Acta (1972) 1.09
Dose-response studies on the ability of 7,12-dimethylbenz(alpha)anthracene and benz(alpha)anthracene to initiate skin tumors. J Natl Cancer Inst (1974) 1.08
Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res (1982) 1.08
Protein kinase C activates the plasma membrane Ca2+ pump isoform 4b by phosphorylation of an inhibitory region downstream of the calmodulin-binding domain. J Biol Chem (1996) 1.07
THE VITAMIN CONTENT OF CASEIN. Science (1945) 1.07
Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer (2001) 1.07
Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol (1989) 1.06
Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer. World J Surg (2015) 1.05
Uptake of insulin by plasmalemma and Golgi subcellular fractions of rat liver. J Biol Chem (1980) 1.05
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect (2004) 1.02
Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency. World J Surg (2008) 1.02
Protein kinase C phosphorylates the "a" forms of plasma membrane Ca2+ pump isoforms 2 and 3 and prevents binding of calmodulin. J Biol Chem (1997) 1.02
Ectopic splenic tissue failed to prevent fatal pneumococcal septicaemia after splenectomy for trauma. Lancet (1980) 1.01
Effect of monochromatic UV radiation on DNA synthesis with in vivo and in vitro autoradiography. J Invest Dermatol (1972) 1.01
Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol Pharmacol (1999) 1.00
Lack of secretion of serum protein by transplanted rat hepatomas. Cancer Res (1966) 1.00
Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons. Carcinogenesis (1982) 1.00
Intracellular hormone receptors: evidence for insulin and lactogen receptors in a unique vesicle sedimenting in lysosome fractions of rat liver. Proc Natl Acad Sci U S A (1981) 1.00
Overexpression of the erythrocyte plasma membrane Ca2+ pump in COS-1 cells. Biochem J (1992) 1.00
Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg (2010) 1.00
Phorbol esters, fatty acids and tumour promotion. Nat New Biol (1973) 0.99
Antibodies directed toward human erythrocyte Ca2+-ATPase: effect on enzyme function and immunoreactivity of Ca2+-ATPases from other sources. Arch Biochem Biophys (1982) 0.98
Direct measurement of specific binding of highly lipophilic phorbol diester to mouse epidermal membranes using cold acetone. Biochem Biophys Res Commun (1981) 0.98
Functional impression technique for an ocular prosthesis. J Indian Prosthodont Soc (2011) 0.98
Cervical lymphadenopathy: scrofula revisited. J Laryngol Otol (2008) 0.98
Stimulation of the phosphorylation of mouse epidermal histones by tumor-promoting agents. Cancer Res (1973) 0.97
Molecular properties of calcium-pumping ATPase from human erythrocytes. Biochemistry (1982) 0.97
Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J Surg (2007) 0.97
Inhibition of both stage I and stage II mouse skin tumour promotion by retinoic acid and the dependence of inhibition of tumor promotion on the duration of retinoic acid treatment. Cancer Res (1987) 0.96
Fine needle aspiration cytology of salivary gland lesions. J Oral Pathol Med (1994) 0.96
Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res (1987) 0.95
The housefly (Musca domestica) as a carrier of pathogenic microorganisms in a hospital environment. J Hosp Infect (1992) 0.95
Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumor-promoting ability. J Natl Cancer Inst (1975) 0.94
Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. Biochem Biophys Res Commun (1982) 0.94
Isolation of phytase-producing bacteria from Himalayan soils and their effect on growth and phosphorus uptake of Indian mustard (Brassica juncea). World J Microbiol Biotechnol (2013) 0.94
Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis. Cancer Res (1971) 0.94
Calcium pump epitopes in placental trophoblast basal plasma membranes. Am J Physiol (1989) 0.93
The early stimulation of phospholipid metabolism by 12-0-tetradecanoyl-phorbol-13-acetate and its specificity for tumor promotion. Cancer Res (1973) 0.93
Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. Cancer Res (1979) 0.93
Studies of the reaction of beta-propiolactone with deoxyguanosine and related compounds. Biochem Pharmacol (1965) 0.92
The effect of the phorbol ester tumor promoters on the basal and catecholamine-stimulated levels of cyclic adenosine 3':5'-monophosphate in mouse skin and epidermis in vivo. Cancer Res (1977) 0.92
Absence of cognitive impairment after more than 100 lifetime ECT treatments. Am J Psychiatry (1991) 0.91
Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol esters. Biochem Biophys Res Commun (1979) 0.91
A high affinity Ca2+-stimulated and Mg2+-dependent ATPase in rat corpus luteum plasma membrane fractions. J Biol Chem (1981) 0.91
Purification of the Ca2+-and Mg2+-requiring ATPase from rat brain synaptic plasma membrane. Biochem J (1982) 0.91
Clinicopathological profile, airway management, and outcome in huge multinodular goiters: an institutional experience from an endemic goiter region. World J Surg (2012) 0.90
Characterization of membrane calcium pumps by simultaneous immunoblotting and 32P radiography. Biochim Biophys Acta (1988) 0.90
Historical perspective: calories and energy expenditure in carcinogenesis. Am J Clin Nutr (1987) 0.90
Myasthenia gravis in young. Indian Pediatr (1986) 0.89
The biochemistry of preneoplasia in mouse skin. Cancer Res (1976) 0.89
Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (1998) 0.89
The inhibition of DNA synthesis by initiators of mouse skin tumorigenesis. Cancer Res (1969) 0.89
Polypeptide hormones: intracellular receptors and internalization. Recent Prog Horm Res (1981) 0.89
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. J Natl Cancer Inst (1993) 0.89
The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides. J Org Chem (1977) 0.88
Plasma membrane Ca(2+) pump isoform 3f is weakly stimulated by calmodulin. J Biol Chem (2000) 0.87
Effects of retinoic acid and juvenile hormone on the induction of ornithine decarboxylase activity by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1978) 0.87
Specific high-affinity binding of the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate to isolated nuclei and nuclear macromolecules in mouse epidermis. Cancer Res (1982) 0.87
Localization of adenosine o',5'-monophosphate in mouse epidermis by immunofluorescence. J Invest Dermatol (1976) 0.87
Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Vaccine (2009) 0.86
Effects of Fasciola gigantica infection on growth and nutrient utilisation of buffalo calves. Vet Rec (1999) 0.86
The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors. Experientia (1986) 0.86